STI tests boost HIV prevention in pregnant women

NCT ID NCT06919614

Recruiting now Prevention Sponsor: Botswana Harvard AIDS Institute Partnership Source: ClinicalTrials.gov ↗

First seen Jun 13, 2026 · Last updated Jun 17, 2026 · Updated 1 time

Summary

This study in Botswana tests whether offering sexually transmitted infection (STI) testing alongside HIV prevention medication (PrEP) helps more pregnant women start and continue using PrEP. About 600 pregnant women without HIV will be split into two groups: one gets standard care, the other gets STI testing for chlamydia, gonorrhea, and trichomonas during pregnancy and after birth. The goal is to see if STI testing encourages better PrEP use and reduces infections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREP ADHERENCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

DHMT Clinics
RECRUITING

Gaborone, Botswana

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

chlamydia infectious disease gonorrhea sexually transmitted disease trichomoniasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREGNANCY PREP ADHERENCE SEXUALLY TRANSMITTED INFECTIONS (STIS)